Cognition Therapeutics, Inc. (CGTX) vs Nutriband Inc. (NTRB)
A side-by-side comparison of Cognition Therapeutics, Inc. and Nutriband Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CGTX
Cognition Therapeutics, Inc.
$0.95HealthcareDelayed quote: Oct 6, 2026, 12:04 PM EDT
NTRB
Nutriband Inc.
$6.70HealthcareDelayed quote: Oct 6, 2026, 11:59 AM EDT
Total return — CGTX vs NTRB
growth of $100 · dividends reinvested · last 5yCGTX -92.7% (-40.7%/yr)NTRB +11.2% (+2.1%/yr)NTRB compounded faster over this window
Log scale — wide-divergence pair
CGTX NTRB
CGTX vs NTRB: by the numbers
- •CGTX is the larger company ($85M vs $81M market cap).
- •Both run net losses; CGTX's is the smaller (0.00% vs -430.43% net margin).
Metrics side by side
Valuation
| Metric | CGTX | NTRB |
|---|---|---|
| Forward P/E | N/A | 4.26 |
| P/S ratio | N/A | 50.31 |
| P/B ratio | 2.56 | 15.28 |
Profitability
| Metric | CGTX | NTRB |
|---|---|---|
| Gross margin | 0.00% | 33.14% |
| Operating margin | 0.00% | -408.41% |
| Net margin | 0.00% | -430.43% |
| ROE | -50.80% | -130.67% |
| ROIC | -109.43% | -126.99% |
Growth (annualized)
| Metric | CGTX | NTRB |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 3.12% |
| Total return CAGR (5Y) | N/A | 6.67% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.